COMPARISON OF ONSET AND RECOVERY FROM FIRST NEUROMUSCULAR BLOCKADE BETWEEN CISATRACURIUM AND ATRACURIUM

ATRACURIUM VERSUS CISATRACURIUM: ONSET AND RECOVERY FROM FIRST NEUROMUSCULAR BLOCKADE IN ADULT SURGICAL PATIENTS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017084

Enrollment

Registered

2019-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CIS-ATRACURIUM: DOSE: 0.15MG/KG IV NEURMUSCULAR BLOCKING AGENT Control Intervention1: ATRACURIUM: DOSE: 0.6MG/KG IV NEUROMUSCULAR BLOCKING AGENT

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS UNDERGOING ANY SURGICAL PROCEDURE UNDER GENERAL ANAESTHESIA REQUIRING NEUROMUSCULAR BLOCKADE

Exclusion criteria

Exclusion criteria: ANTICIPATED DIFFICULT INTUBATION RISK OF ASPIRATION ASA GRADE 3 AND ABOVE HYPERSENSITVITY TO NEUROMUSCULAR BLOCKING AGENTS PATIENTS WITH HEPATIC OR RENAL DISEASE BMI MORE THAN 30

Design outcomes

Primary

Measure	Time frame
ONSET OF ACTION HAEMODYNAMIC STABILITY RECOVERY FROM FIRST LOADING DOSE OF CIS-ATRACURIUM AND ATRACURIUMTimepoint: ONSET OF ACTION HAEMODYNAMIC STABILITY RECOVERY FROM FIRST LOADING DOSE OF CIS-ATRACURIUM AND ATRACURIUM	—

Secondary

Measure	Time frame
INTUBATING CONDITIONS ADVERSE REACTIONSTimepoint: 5 MINUTES	—

Countries

India

Contacts

Public ContactDr Palak R Bohra

MGM MEDICAL COLLEGE AND HOSPITAL

drsanhitakulkarni@gmail.com9881300645

Outcome results